Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. ADAMTS2 - Wikipedia
ADAMTS2 - Wikipedia
From Wikipedia, the free encyclopedia
Protein-coding gene in the species Homo sapiens
ADAMTS2
Identifiers
AliasesADAMTS2, ADAM-TS2, ADAMTS-2, ADAMTS-3, NPI, PC I-NP, PCI-NP, PCINP, PCPNI, PNPI, ADAM metallopeptidase with thrombospondin type 1 motif 2, EDSDERMS
External IDsOMIM: 604539; MGI: 1347356; HomoloGene: 8597; GeneCards: ADAMTS2; OMA:ADAMTS2 - orthologs
Gene location (Mouse)
Chromosome 11 (mouse)
Chr.Chromosome 11 (mouse)[1]
Chromosome 11 (mouse)
Genomic location for ADAMTS2
Genomic location for ADAMTS2
Band11|11 B1.3Start50,492,911 bp[1]
End50,698,400 bp[1]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • stromal cell of endometrium

  • subcutaneous adipose tissue

  • right lung

  • right coronary artery

  • spleen

  • left coronary artery

  • upper lobe of left lung

  • gastric mucosa

  • myometrium

  • left uterine tube
Top expressed in
  • ascending aorta

  • aortic valve

  • decidua

  • gastrula

  • umbilical cord

  • stroma of bone marrow

  • body of femur

  • ankle

  • cervix

  • vas deferens
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • zinc ion binding
  • peptidase activity
  • metalloendopeptidase activity
  • hydrolase activity
  • metallopeptidase activity
  • metal ion binding
Cellular component
  • extracellular region
  • collagen-containing extracellular matrix
  • extracellular matrix
Biological process
  • collagen catabolic process
  • protein processing
  • spermatogenesis
  • skin development
  • collagen fibril organization
  • lung development
  • proteolysis
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

9509

216725

Ensembl

n/a

ENSMUSG00000036545

UniProt

O95450

Q8C9W3

RefSeq (mRNA)

NM_021599
NM_014244

NM_001277305
NM_175643

RefSeq (protein)

NP_055059
NP_067610

NP_783574

Location (UCSC)n/aChr 11: 50.49 – 50.7 Mb
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS2) also known as procollagen I N-proteinase (PC I-NP) is an enzyme[4] that in humans is encoded by the ADAMTS2 gene.[5][6]

Gene

[edit]

The ADAMTS2 gene is located on the long (q) arm of chromosome 5 at the end (terminus) of the arm, from base pair 178,473,473 to base pair 178,704,934.

Function

[edit]

ADAMTS2 is responsible for processing several types of procollagen proteins. Procollagens are the precursors of collagens, the proteins that add strength and support to many body tissues. Specifically, this enzyme clips a short chain of amino acids off one end of the procollagen. This clipping step is necessary for collagen molecules to function normally and assemble into fibrils outside cells.

Clinical significance

[edit]

Ehlers-Danlos syndrome, dermatosparaxis type is caused by mutations in the ADAMTS2 gene.[6] Several mutations in the ADAMTS2 gene have been identified in people with this syndrome. These mutations greatly reduce the production of the enzyme made by the ADAMTS2 gene. Procollagen cannot be processed correctly without this enzyme. As a result, collagen fibrils are not assembled properly; they appear ribbon-like and disorganized under the microscope. Cross-links, or chemical interactions, between collagen fibrils are also affected. These defects weaken connective tissue (the tissue that binds and supports the body's muscles, ligaments, organs, and skin), which causes the signs and symptoms of the disorder.

See also

[edit]
  • ADAMTS5
  • ADAMTS13

References

[edit]
  1. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000036545 – Ensembl, May 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ Tang BL, Hong W (February 1999). "ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats". FEBS Lett. 445 (2–3): 223–5. Bibcode:1999FEBSL.445..223T. doi:10.1016/S0014-5793(99)00119-2. PMID 10094461. S2CID 37955930.
  5. ^ "Entrez Gene: ADAM metallopeptidase with thrombospondin type 1 motif".
  6. ^ a b Colige A, Nuytinck L, Hausser I, van Essen AJ, Thiry M, Herens C, Adès LC, Malfait F, Paepe AD, Franck P, Wolff G, Oosterwijk JC, Smitt JH, Lapière CM, Nusgens BV (October 2004). "Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene". J. Invest. Dermatol. 123 (4): 656–63. doi:10.1111/j.0022-202X.2004.23406.x. PMID 15373769.[permanent dead link]

Further reading

[edit]
  • Wang WM, Lee S, Steiglitz BM, Scott IC, Lebares CC, Allen ML, Brenner MC, Takahara K, Greenspan DS (May 2003). "Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase". J. Biol. Chem. 278 (21): 19549–57. doi:10.1074/jbc.M300767200. PMID 12646579.
  • Reardon W, Winter RM, Smith LT, et al. (1995). "The natural history of human dermatosparaxis (Ehlers-Danlos syndrome type VIIC)". Clin. Dysmorphol. 4 (1): 1–11. doi:10.1097/00019605-199501000-00001. PMID 7735500. S2CID 2412884.
  • Colige A, Vandenberghe I, Thiry M, et al. (2002). "Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3". J. Biol. Chem. 277 (8): 5756–66. doi:10.1074/jbc.M105601200. PMID 11741898.
  • Kevorkian L, Young DA, Darrah C, et al. (2004). "Expression profiling of metalloproteinases and their inhibitors in cartilage". Arthritis Rheum. 50 (1): 131–41. doi:10.1002/art.11433. PMID 14730609.
  • Hurskainen TL, Hirohata S, Seldin MF, Apte SS (1999). "ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family". J. Biol. Chem. 274 (36): 25555–63. doi:10.1074/jbc.274.36.25555. PMID 10464288.
  • Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
  • Dubail J, Kesteloot F, Deroanne C, et al. (2010). "ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity" (PDF). Cellular and Molecular Life Sciences. 67 (24): 4213–32. doi:10.1007/s00018-010-0431-6. hdl:2268/73235. PMC 11115784. PMID 20574651. S2CID 20047628. Archived from the original (PDF) on 2022-02-26. Retrieved 2019-09-26.
  • Colige A, Sieron AL, Li SW, et al. (1999). "Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene". Am. J. Hum. Genet. 65 (2): 308–17. doi:10.1086/302504. PMC 1377929. PMID 10417273.
  • Hartley JL, Temple GF, Brasch MA (2000). "DNA Cloning Using In Vitro Site-Specific Recombination". Genome Res. 10 (11): 1788–95. doi:10.1101/gr.143000. PMC 310948. PMID 11076863.
  • Tang BL (2001). "ADAMTS: a novel family of extracellular matrix proteases". Int. J. Biochem. Cell Biol. 33 (1): 33–44. doi:10.1016/S1357-2725(00)00061-3. PMID 11167130.
  • Lasky-Su J, Anney RJ, Neale BM, et al. (2008). "Genome-wide association scan of the time to onset of Attention Deficit Hyperactivity Disorder". Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (8): 1355–8. doi:10.1002/ajmg.b.30869. PMC 2605611. PMID 18937294.
  • Colige A, Ruggiero F, Vandenberghe I, et al. (2005). "Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V". J. Biol. Chem. 280 (41): 34397–408. doi:10.1074/jbc.M506458200. PMID 16046392.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Brandenberger R, Wei H, Zhang S, et al. (2004). "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation". Nat. Biotechnol. 22 (6): 707–16. doi:10.1038/nbt971. PMID 15146197. S2CID 27764390.
  • Tomii Y, Kamochi J, Yamazaki H, et al. (2002). "Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells". Int. J. Oncol. 20 (2): 339–42. doi:10.3892/ijo.20.2.339. PMID 11788898.

External links

[edit]
  • GeneCard
  • The MEROPS online database for peptidases and their inhibitors: M12.301 Deprecated link archived 2012-12-23 at archive.today
  • Human ADAMTS2 genome location and ADAMTS2 gene details page in the UCSC Genome Browser.
  • v
  • t
  • e
Protein: scleroproteins
Extracellular
matrix
Collagen
Fibril forming
  • type I
    • COL1A1
    • COL1A2
  • type II (COL2A1)
  • type III
  • type V
    • COL5A1
    • COL5A2
    • COL5A3
  • COL24A1
  • COL26A1
Other
  • FACIT: type IX
    • COL9A1
    • COL9A2
    • COL9A3
  • type XII (COL12A1)
  • COL14A1
  • COL16A1
  • COL19A1
  • COL20A1
  • COL21A1
  • COL22A1
  • basement membrane: type IV
    • COL4A1
    • COL4A2
    • COL4A3
    • COL4A4
    • COL4A5
    • COL4A6
  • multiplexin: COL15A1
  • type XVIII
    • COL18A1
    • Endostatin
  • transmembrane: COL13A1
  • COL17A1
  • COL23A1
  • COL25A1
  • other: type VI
    • COL6A1
    • COL6A2
    • COL6A3
    • COL6A5
  • type VII (COL7A1)
  • type VIII
    • COL8A1
    • COL8A2
  • type X (COL10A1)
  • type XI
    • COL11A1
    • COL11A2
  • COL27A1
  • COL28A1
Enzymes
  • Prolyl hydroxylase/Lysyl hydroxylase
  • Cartilage associated protein/Leprecan
  • ADAMTS2
  • Procollagen peptidase
  • Lysyl oxidase
Laminin
  • alpha
    • LAMA1
    • LAMA2
    • LAMA3
    • LAMA4
    • LAMA5
  • beta
    • LAMB1
    • LAMB2
    • LAMB3
    • LAMB4
  • gamma
    • LAMC1
    • LAMC2
    • LAMC3
Other
  • ALCAM
  • Elastin
    • Tropoelastin
  • Vitronectin
  • FRAS1
  • FREM2
  • Decorin
  • FAM20C
  • ECM1
  • Matrix gla protein
  • Tectorin
    • TECTA
    • TECTB
Other
  • Keratin/Cytokeratin
  • Gelatin
  • Reticulin
  • Cartilage oligomeric matrix protein
See also
diseases
  • v
  • t
  • e
Proteases: metalloendopeptidases (EC 3.4.24)
ADAM proteins
  • Alpha secretases
    • ADAM9
    • ADAM10
    • ADAM17
    • ADAM19
  • ADAM2
  • ADAM7
  • ADAM8
  • ADAM11
  • ADAM12
  • ADAM15
  • ADAM18
  • ADAM22
  • ADAM23
  • ADAM28
  • ADAM33
  • ADAMTS1
  • ADAMTS2
  • ADAMTS3
  • ADAMTS4
  • ADAMTS5
  • ADAMTS8
  • ADAMTS9
  • ADAMTS10
  • ADAMTS12
  • ADAMTS13
Matrix metalloproteinases
  • Collagenases
    • MMP1
    • MMP8
  • Gelatinases
    • MMP2
    • MMP9
  • MMP3
  • MMP7
  • MMP10
  • MMP11
  • MMP12
  • MMP13
  • MMP14
  • MMP15
  • MMP16
  • MMP17
  • MMP19
  • MMP20
  • MMP21
  • MMP23A
  • MMP23B
  • MMP24
  • MMP25
  • MMP26
  • MMP27
  • MMP28
Other
  • Neprilysin
  • Procollagen peptidase
  • Thermolysin
  • Pregnancy-associated plasma protein A
  • Bone morphogenetic protein 1
  • Lysostaphin
  • Insulin-degrading enzyme
  • ZMPSTE24
  • v
  • t
  • e
Enzymes
Activity
  • Active site
  • Binding site
  • Catalytic triad
  • Oxyanion hole
  • Enzyme promiscuity
  • Diffusion-limited enzyme
  • Cofactor
  • Enzyme catalysis
Regulation
  • Allosteric regulation
  • Cooperativity
  • Enzyme inhibitor
  • Enzyme activator
Classification
  • EC number
  • Enzyme superfamily
  • Enzyme family
  • List of enzymes
Kinetics
  • Enzyme kinetics
  • Eadie–Hofstee diagram
  • Hanes–Woolf plot
  • Lineweaver–Burk plot
  • Michaelis–Menten kinetics
Types
  • EC1 Oxidoreductases (list)
  • EC2 Transferases (list)
  • EC3 Hydrolases (list)
  • EC4 Lyases (list)
  • EC5 Isomerases (list)
  • EC6 Ligases (list)
  • EC7 Translocases (list)
Portal:
  • icon Biology
Retrieved from "https://teknopedia.ac.id/w/index.php?title=ADAMTS2&oldid=1301331116"
Categories:
  • Human genes
  • EC 3.4.24
  • ADAMTS
Hidden categories:
  • All articles with dead external links
  • Articles with dead external links from July 2023
  • Articles with permanently dead external links
  • Articles with short description
  • Short description matches Wikidata
  • Webarchive template archiveis links

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id